These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36536076)

  • 21. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
    Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
    Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. α-Cyperone protects dopaminergic neurons and inhibits neuroinflammation in LPS-induced Parkinson's disease rat model via activating Nrf2/HO-1 and suppressing NF-κB signaling pathway.
    Huang B; Hu G; Zong X; Yang S; He D; Gao X; Liu D
    Int Immunopharmacol; 2023 Feb; 115():109698. PubMed ID: 36634417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of neuroinflammation by MIF inhibitor 3-({[4-(4-methoxyphenyl)-6-methyl-2-pyrimidinyl]thio}1methyl)benzoic acid (Z-312).
    Zheng LT; Chen J; Zhang L; Zhang Y; Xu L; Hou T; Zhen X; Dai Q; Liu H
    Int Immunopharmacol; 2021 Sep; 98():107868. PubMed ID: 34153665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson's disease models.
    Liu Z; Shen C; Li H; Tong J; Wu Y; Ma Y; Wang J; Wang Z; Li Q; Zhang X; Dong H; Yang Y; Yu M; Wang J; Zhou R; Fei J; Huang F
    J Neuroinflammation; 2023 Apr; 20(1):96. PubMed ID: 37072793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatostatin prevents lipopolysaccharide-induced neurodegeneration in the rat substantia nigra by inhibiting the activation of microglia.
    Bai L; Zhang X; Li X; Liu N; Lou F; Ma H; Luo X; Ren Y
    Mol Med Rep; 2015 Jul; 12(1):1002-8. PubMed ID: 25777539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dihydroquercetin alleviates dopamine neuron loss via regulating TREM2 activation.
    Yang R; Li DD; Li XX; Yang XX; Gao HM; Zhang F
    Int J Biol Macromol; 2024 Jun; 269(Pt 2):132179. PubMed ID: 38723817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Echinacoside protects dopaminergic neurons by inhibiting NLRP3/Caspase-1/IL-1β signaling pathway in MPTP-induced Parkinson's disease model.
    Gao MR; Wang M; Jia YY; Tian DD; Liu A; Wang WJ; Yang L; Chen JY; Yang Q; Liu R; Wu YM
    Brain Res Bull; 2020 Nov; 164():55-64. PubMed ID: 32846198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease.
    George S; Rey NL; Tyson T; Esquibel C; Meyerdirk L; Schulz E; Pierce S; Burmeister AR; Madaj Z; Steiner JA; Escobar Galvis ML; Brundin L; Brundin P
    Mol Neurodegener; 2019 Aug; 14(1):34. PubMed ID: 31419995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plantamajoside Alleviates Substantia Nigra Damage in Parkinson's Disease Mice by Inhibiting HDAC2/MAPK Signaling and Reducing Microglia Polarization.
    Guo X; Chen L; Li J
    ACS Chem Neurosci; 2023 Mar; 14(6):1119-1125. PubMed ID: 36859770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triptolide up-regulates metabotropic glutamate receptor 5 to inhibit microglia activation in the lipopolysaccharide-induced model of Parkinson's disease.
    Huang YY; Zhang Q; Zhang JN; Zhang YN; Gu L; Yang HM; Xia N; Wang XM; Zhang H
    Brain Behav Immun; 2018 Jul; 71():93-107. PubMed ID: 29649522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peiminine Protects Dopaminergic Neurons from Inflammation-Induced Cell Death by Inhibiting the ERK1/2 and NF-κB Signalling Pathways.
    Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Liu D; Fu S
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel compound VSC2 has anti-inflammatory and antioxidant properties in microglia and in Parkinson's disease animal model.
    Lee JA; Kim JH; Woo SY; Son HJ; Han SH; Jang BK; Choi JW; Kim DJ; Park KD; Hwang O
    Br J Pharmacol; 2015 Feb; 172(4):1087-100. PubMed ID: 25297649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis.
    Huang B; Liu J; Meng T; Li Y; He D; Ran X; Chen G; Guo W; Kan X; Fu S; Wang W; Liu D
    Front Immunol; 2018; 9():2527. PubMed ID: 30455692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of HCA2 regulates microglial responses to alleviate neurodegeneration in LPS-induced in vivo and in vitro models.
    He D; Fu S; Ye B; Wang H; He Y; Li Z; Li J; Gao X; Liu D
    J Neuroinflammation; 2023 Mar; 20(1):86. PubMed ID: 36991440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rubusoside mitigates neuroinflammation and cellular apoptosis in Parkinson's disease, and alters gut microbiota and metabolite composition.
    Meng T; Zhang Y; Huang J; Pandey V; Fu S; Ma S
    Phytomedicine; 2024 Feb; 124():155309. PubMed ID: 38237261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of preconditioning with low dose of LPS on paraquat-induced neurotoxicity, microglia activation and expression of α-synuclein and synphilin-1 in the dopaminergic system.
    Kuter KZ; Śmiałowska M; Ossowska K
    Pharmacol Rep; 2022 Feb; 74(1):67-83. PubMed ID: 34762280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DJ-1 inhibits microglial activation and protects dopaminergic neurons in vitro and in vivo through interacting with microglial p65.
    Lin Z; Chen C; Yang D; Ding J; Wang G; Ren H
    Cell Death Dis; 2021 Jul; 12(8):715. PubMed ID: 34274951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Auraptene and Other Prenyloxyphenylpropanoids Suppress Microglial Activation and Dopaminergic Neuronal Cell Death in a Lipopolysaccharide-Induced Model of Parkinson's Disease.
    Okuyama S; Semba T; Toyoda N; Epifano F; Genovese S; Fiorito S; Taddeo VA; Sawamoto A; Nakajima M; Furukawa Y
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ellagic Acid Protects Dopamine Neurons via Inhibition of NLRP3 Inflammasome Activation in Microglia.
    He XM; Zhou YZ; Sheng S; Li JJ; Wang GQ; Zhang F
    Oxid Med Cell Longev; 2020; 2020():2963540. PubMed ID: 33294118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways.
    Li Y; Zeng Y; Meng T; Gao X; Huang B; He D; Ran X; Du J; Zhang Y; Fu S; Hu G
    Int Immunopharmacol; 2019 Oct; 75():105739. PubMed ID: 31351366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.